ArticleCureus2026
Alpha-1 Antitrypsin PiMZ Heterozygosity in the Setting of Alcohol-Associated Cirrhosis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alpha-1 antitrypsin deficiency (AATD) is classically associated with the PiZZ genotype, while PiMZ heterozygosity has historically been considered a benign carrier state. Emerging evidence, however, suggests PiMZ status functions as a clinically significant cofactor for liver fibrosis when combined with metabolic or environmental stressors such as alcohol use. We present the case of a 57-year-old woman with a diagnosis of cirrhosis of unclear etiology and a remote history of alcohol use, who was admitted with jaundice and profound hyponatremia. Workup for viral, autoimmune, and hereditary hemochromatosis etiologies was unrevealing. Transjugular liver biopsy demonstrated periodic acid-Schiff-positive, diastase-resistant (PAS-D) intrahepatocytic globules with mild siderosis; subsequent testing revealed a low serum alpha-1 antitrypsin (A1AT) level and PiMZ genotype. This case illustrates the diagnostic value of liver biopsy in identifying AATD-pattern globules and prompting confirmatory serum and genotypic testing. Although this patient's serum AAT was notably reduced - a diagnostically helpful but not universal finding, as many PiMZ carriers have levels near the normal range - the case underscores that biopsy and genotyping remain essential for diagnosis regardless of serum AAT level. It further reflects the growing recognition that PiMZ heterozygosity, particularly in the presence of alcohol exposure, may meaningfully contribute to progression toward decompensated cirrhosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.